REV	B-GP
-	I-GP
ERBα	I-GP
regulates	O
Fgf21	B-GP
expression	O
in	O
the	O
liver	O
via	O
hepatic	B-GP
nuclear	I-GP
factor	I-GP
6	I-GP

ABSTRACT	O

The	O
circadian	O
clock	B-GP
contributes	O
to	O
the	O
timing	O
of	O
many	O
body	O
functions	O
including	O
metabolism	O
and	O
reproduction	O
.	O

The	O
hepatokine	B-GP
fibroblast	B-GP
growth	I-GP
factor	I-GP
21	I-GP
(	O
FGF21	B-GP
)	O
is	O
a	O
critical	O
metabolic	O
regulator	O
involved	O
in	O
modulation	O
of	O
fertility	O
.	O

Here	O
we	O
show	O
that	O
lack	O
of	O
the	O
clock	B-GP
component	O
REV	B-GP
-	I-GP
ERBα	I-GP
elevates	O
FGF21	B-GP
levels	O
in	O
liver	O
and	O
plasma	O
.	O

At	O
the	O
molecular	O
level	O
,	O
REV	B-GP
-	I-GP
ERBα	I-GP
modulates	O
the	O
expression	O
of	O
FGF21	B-GP
via	O
the	O
liver	O
-	O
specific	O
hepatic	B-GP
nuclear	I-GP
factor	I-GP
6	I-GP
(	O
HNF6	B-GP
).	O

We	O
conclude	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
regulates	O
metabolism	O
and	O
reproduction	O
,	O
at	O
least	O
in	O
part	O
,	O
via	O
regulation	O
of	O
Fgf21	B-GP
.	O

Summary	O
:	O
The	O
hepatokine	O
Fgf21	B-GP
is	O
transcriptionally	O
regulated	O
by	O
the	O
nuclear	O
receptor	O
REV	B-GP
-	I-GP
ERBα	I-GP
with	O
the	O
hepatocyte	O
-	O
specific	O
factor	O
HNF6	B-GP
to	O
regulate	O
metabolism	O
and	O
fertility	O
.	O

INTRODUCTION	O

The	O
circadian	O
clock	B-GP
allows	O
organisms	O
to	O
predict	O
daily	O
recurring	O
events	O
such	O
as	O
sunrise	O
,	O
emergence	O
of	O
a	O
particular	O
food	O
source	O
and	O
presence	O
of	O
predators	O
.	O

This	O
enables	O
them	O
to	O
optimally	O
time	O
physiological	O
processes	O
to	O
the	O
environment	O
in	O
order	O
to	O
enhance	O
survival	O
.	O

For	O
the	O
survival	O
of	O
the	O
species	O
,	O
successful	O
reproduction	O
is	O
essential	O
and	O
factors	O
enhancing	O
the	O
chance	O
of	O
reproductive	O
success	O
are	O
conserved	O
.	O

Since	O
the	O
circadian	O
system	O
not	O
only	O
synchronizes	O
physiology	O
and	O
behavior	O
in	O
an	O
organism	O
,	O
but	O
also	O
is	O
able	O
to	O
adapt	O
to	O
environmental	O
changes	O
such	O
as	O
seasons	O
,	O
it	O
is	O
not	O
surprising	O
that	O
de	O
-	O
synchronization	O
of	O
the	O
circadian	O
system	O
or	O
mutation	O
in	O
clock	B-GP
genes	O
can	O
affect	O
reproductive	O
capacity	O
(	O
Ikegami	O
and	O
Yoshimura	O
,	O
2012	O
;	O
Boden	O
et	O
al	O
.,	O
2013	O
).	O

Lack	O
of	O
the	O
clock	B-GP
gene	O
Bmal1	B-GP
in	O
mice	B-OG
leads	O
to	O
irregular	O
estrous	O
cycles	O
(	O
Ratajczak	O
et	O
al	O
.,	O
2009	O
)	O
and	O
impaired	O
ovulation	O
(	O
Boden	O
et	O
al	O
.,	O
2010	O
)	O
for	O
which	O
Bmal1	B-GP
in	O
ovarian	O
theca	O
cells	O
appears	O
to	O
be	O
important	O
(	O
Mereness	O
et	O
al	O
.,	O
2015	O
).	O

Furthermore	O
,	O
mice	B-OG
with	O
a	O
mutation	O
in	O
the	O
Clock	B-GP
gene	O
also	O
display	O
an	O
irregular	O
estrous	O
cycle	O
(	O
Kennaway	O
et	O
al	O
.,	O
2004	O
;	O
Miller	O
et	O
al	O
.,	O
2004	O
),	O
and	O
Per1	B-GP
/	O
Per2	B-GP
mutants	O
develop	O
irregular	O
estrous	O
cycles	O
as	O
they	O
age	O
(	O
Pilorz	O
and	O
Steinlechner	O
,	O
2008	O
).	O

The	O
nuclear	O
receptor	O
and	O
clock	B-GP
component	O
REV	B-GP
-	I-GP
ERBα	I-GP
is	O
expressed	O
with	O
a	O
circadian	O
rhythm	O
and	O
represses	O
Bmal1	B-GP
(	O
Preitner	O
et	O
al	O
.,	O
2002	O
),	O
encoding	O
a	O
positive	O
regulator	O
of	O
clock	B-GP
output	O
genes	O
.	O

REV	B-GP
-	I-GP
ERBα	I-GP
also	O
represses	O
other	O
genes	O
to	O
regulate	O
metabolism	O
in	O
a	O
tissue	O
-	O
dependent	O
manner	O
(	O
Cho	O
et	O
al	O
.,	O
2012	O
;	O
Bugge	O
et	O
al	O
.,	O
2012	O
).	O

Hence	O
,	O
REV	B-GP
-	I-GP
ERBα	I-GP
is	O
central	O
to	O
regulate	O
complex	O
interactions	O
between	O
the	O
circadian	O
clock	B-GP
and	O
metabolism	O
.	O

Female	O
mice	B-OG
lacking	O
Rev	B-GP
-	I-GP
erbα	I-GP
display	O
reduced	O
fertility	O
while	O
males	O
appear	O
to	O
mate	O
and	O
reproduce	O
normally	O
(	O
Chomez	O
et	O
al	O
.,	O
2000	O
).	O

Recent	O
studies	O
indicate	O
that	O
the	O
reproductive	O
axis	O
and	O
metabolism	O
are	O
sensitive	O
to	O
fibroblast	B-GP
growth	I-GP
factor	I-GP
21	I-GP
(	O
FGF21	B-GP
)	O
(	O
Owen	O
et	O
al	O
.,	O
2013	O
;	O
Nies	O
et	O
al	O
.,	O
2016	O
).	O

FGF21	B-GP
is	O
a	O
member	O
of	O
the	O
endocrine	O
FGF	B-GP
subfamily	O
that	O
is	O
a	O
critical	O
metabolic	O
regulator	O
(	O
Itoh	O
,	O
2010	O
;	O
Reitman	O
,	O
2007	O
;	O
Beenken	O
and	O
Mohammadi	O
,	O
2009	O
)	O
and	O
over	O
-	O
expression	O
of	O
Fgf21	B-GP
renders	O
female	O
mice	B-OG
infertile	O
(	O
Owen	O
et	O
al	O
.,	O
2013	O
;	O
Inagaki	O
et	O
al	O
.,	O
2007	O
).	O

Because	O
the	O
Fgf21	B-GP
promoter	O
contains	O
nuclear	O
receptor	O
response	O
elements	O
and	O
E	O
-	O
boxes	O
(	O
Estall	O
et	O
al	O
.,	O
2009	O
;	O
Tong	O
et	O
al	O
.,	O
2010	O
),	O
we	O
investigated	O
whether	O
Fgf21	B-GP
is	O
regulated	O
directly	O
or	O
indirectly	O
by	O
clock	B-GP
components	O
.	O

We	O
find	O
that	O
Fgf21	B-GP
is	O
regulated	O
indirectly	O
by	O
the	O
nuclear	O
receptors	O
REV	B-GP
-	I-GP
ERBα	I-GP
via	O
HNF6	B-GP
,	O
and	O
the	O
clock	B-GP
protein	O
PER2	B-GP
modulates	O
the	O
repressive	O
function	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
and	O
/	O
or	O
the	O
transcriptional	O
efficiency	O
of	O
PPARα	B-GP
-	O
mediated	O
expression	O
of	O
Fgf21	B-GP
.	O

Thus	O
,	O
FGF21	B-GP
may	O
be	O
an	O
intermediary	O
between	O
the	O
clock	B-GP
components	O
,	O
metabolism	O
and	O
reproductive	O
fitness	O
.	O

RESULTS	O

Rev	B-GP
-	I-GP
erbα	I-GP
knock	O
-	O
out	O
mice	B-OG
display	O
reduced	O
fertility	O

Breeding	O
of	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
animals	B-OG
in	O
our	O
facility	O
revealed	O
reduced	O
fertility	O
of	O
these	O
animals	B-OG
,	O
with	O
the	O
average	O
number	O
of	O
pups	O
per	O
mating	O
pair	O
reduced	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
compared	O
to	O
the	O
heterozygous	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
breeding	O
pairs	O
(	O
Fig	O
.	O
1A	O
).	O

Interestingly	O
,	O
also	O
the	O
number	O
of	O
litters	O
per	O
mating	O
period	O
was	O
reduced	O
(	O
Fig	O
.	O
1B	O
)	O
indicating	O
that	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
breeding	O
pairs	O
took	O
longer	O
to	O
produce	O
offspring	O
(	O
Fig	O
.	O
1C	O
).	O

This	O
observation	O
is	O
consistent	O
with	O
a	O
previous	O
report	O
describing	O
reduced	O
reproduction	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
knock	O
-	O
out	O
mice	B-OG
(	O
Chomez	O
et	O
al	O
.,	O
2000	O
).	O
Fig	O
.	O
1	O
.	O
Female	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
display	O
signs	O
of	O
reduced	O
fertility	O
.	O
(	O
A	O
)	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
bar	O
)	O
mating	O
pairs	O
produce	O
significantly	O
less	O
pups	O
per	O
litter	O
compared	O
to	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
(	O
black	O
bar	O
)	O
pairs	O
.	O

Unpaired	O
two	O
-	O
tailed	O
t	O
-	O
test	O
,	O
***	O
P	O
<	O
0	O
.	O
0001	O
,	O
n	O
=	O
18	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
and	O
n	O
=	O
8	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−,	O
F	O
-	O
test	O
reveals	O
no	O
difference	O
in	O
variance	O
,	O
F	O
=	O
2	O
.	O
41	O
,	O
DFn	O
=	O
17	O
,	O
Dfd	O
=	O
7	O
.	O

(	O
B	O
)	O
Number	O
of	O
litters	O
per	O
mating	O
period	O
is	O
reduced	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
bar	O
)	O
mating	O
pairs	O
compared	O
to	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
(	O
black	O
bar	O
)	O
pairs	O
.	O

Unpaired	O
two	O
-	O
tailed	O
t	O
-	O
test	O
,	O
***	O
P	O
<	O
0	O
.	O
0001	O
,	O
n	O
=	O
13	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
and	O
n	O
=	O
8	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−,	O
F	O
-	O
test	O
reveals	O
difference	O
in	O
variance	O
,	O
F	O
=	O
51	O
.	O
38	O
,	O
DFn	O
=	O
12	O
,	O
Dfd	O
=	O
7	O
.	O

(	O
C	O
)	O
Inter	O
-	O
litter	O
period	O
is	O
significantly	O
longer	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
bar	O
)	O
compared	O
to	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
(	O
black	O
bar	O
)	O
mating	O
pairs	O
.	O

Unpaired	O
two	O
-	O
tailed	O
t	O
-	O
test	O
,	O
***	O
P	O
<	O
0	O
.	O
0001	O
,	O
n	O
=	O
16	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/−	O
and	O
n	O
=	O
6	O
for	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−,	O
F	O
-	O
test	O
reveals	O
difference	O
in	O
variance	O
,	O
F	O
=	O
8	O
.	O
793	O
,	O
DFn	O
=	O
5	O
,	O
Dfd	O
=	O
15	O
.	O

(	O
D	O
)	O
Hepatic	O
Fgf21	B-GP
mRNA	O
in	O
the	O
liver	O
is	O
increased	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
line	O
)	O
compared	O
to	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/+	O
mice	B-OG
(	O
black	O
line	O
).	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
test	O
.	O

The	O
two	O
curves	O
are	O
significantly	O
different	O
,	O
P	O
=	O
0	O
.	O
0008	O
,	O
n	O
=	O
4	O
.	O

(	O
E	O
)	O
Plasma	O
FGF21	B-GP
protein	O
levels	O
are	O
significantly	O
increased	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
line	O
)	O
compared	O
to	O
Rev	B-GP
-	I-GP
erbα	I-GP
+/+	O
animals	B-OG
(	O
black	O
line	O
).	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
test	O
.	O

The	O
two	O
curves	O
are	O
significantly	O
different	O
,	O
P	O
=	O
0	O
.	O
0003	O
,	O
n	O
=	O
4	O
-	O
6	O
.	O

All	O
values	O
are	O
mean	O
±	O
s	O
.	O
e	O
.	O
m	O
.	O

Recent	O
studies	O
indicate	O
that	O
the	O
reproductive	O
axis	O
is	O
sensitive	O
to	O
fibroblast	B-GP
growth	I-GP
factor	I-GP
21	I-GP
(	O
FGF21	B-GP
)	O
(	O
Owen	O
et	O
al	O
.,	O
2013	O
).	O

The	O
phenotype	O
displayed	O
by	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
is	O
reminiscent	O
of	O
animals	B-OG
overexpressing	O
Fgf21	B-GP
(	O
Owen	O
et	O
al	O
.,	O
2013	O
),	O
therefore	O
,	O
we	O
tested	O
whether	O
Fgf21	B-GP
expression	O
is	O
altered	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
.	O

We	O
found	O
that	O
Fgf21	B-GP
mRNA	O
was	O
diurnally	O
expressed	O
in	O
the	O
liver	O
of	O
wild	O
-	O
type	O
mice	B-OG
in	O
a	O
similar	O
fashion	O
as	O
Bmal1	B-GP
mRNA	O
,	O
a	O
REV	B-GP
-	I-GP
ERBα	I-GP
target	O
gene	O
(	O
Preitner	O
et	O
al	O
.,	O
2002	O
)	O
and	O
in	O
an	O
inverted	O
diurnal	O
pattern	O
compared	O
to	O
the	O
E	O
-	O
box	O
-	O
driven	O
Per1	B-GP
gene	O
(	O
Preitner	O
et	O
al	O
.,	O
2002	O
)	O
(	O
Fig	O
.	O
1D	O
).	O
Fgf21	B-GP
mRNA	O
expression	O
was	O
increased	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
at	O
all	O
time	O
points	O
over	O
the	O
day	O
compared	O
to	O
controls	O
(	O
Fig	O
.	O
1D	O
).	O

Similarly	O
,	O
FGF21	B-GP
protein	O
levels	O
were	O
also	O
increased	O
in	O
plasma	O
of	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
with	O
pronounced	O
elevation	O
at	O
Zeitgeber	O
time	O
(	O
ZT	O
)	O
12	O
and	O
ZT18	O
(	O
Fig	O
.	O
1E	O
),	O
but	O
plasma	O
FGF21	B-GP
levels	O
were	O
not	O
diurnal	O
in	O
wild	O
-	O
type	O
animals	B-OG
(	O
Fig	O
.	O
1E	O
).	O

Since	O
REV	B-GP
-	I-GP
ERBα	I-GP
is	O
a	O
nuclear	O
receptor	O
with	O
repressive	O
potential	O
,	O
we	O
tested	O
whether	O
REV	B-GP
-	I-GP
ERBα	I-GP
can	O
directly	O
regulate	O
the	O
Fgf21	B-GP
promoter	O
.	O

Fgf21	B-GP
is	O
regulated	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
/	O
HNF6	B-GP
and	O
PPARα	B-GP
/	O
RXRα	B-GP

Bioinformatic	O
analysis	O
of	O
the	O
Fgf21	B-GP
promoter	O
revealed	O
the	O
presence	O
of	O
E	O
-	O
box	O
elements	O
to	O
which	O
the	O
circadian	O
clock	B-GP
factors	O
BMAL1	B-GP
/	O
CLOCK	B-GP
bind	O
as	O
heterodimers	O
.	O

Furthermore	O
,	O
we	O
identified	O
REV	B-GP
-	I-GP
ERBα	I-GP
binding	O
sites	O
,	O
so	O
-	O
called	O
putative	O
retinoid	B-GP
orphan	I-GP
receptor	I-GP
elements	O
(	O
ROREs	O
)	O
and	O
PPARα	B-GP
binding	O
sites	O
(	O
PPARE	O
).	O

In	O
a	O
first	O
step	O
we	O
tested	O
activation	O
of	O
the	O
Fgf21	B-GP
promoter	O
by	O
BMAL1	B-GP
and	O
CLOCK	B-GP
using	O
a	O
transactivation	O
assay	O
.	O

A	O
3	O
.	O
1	O
kB	O
-	O
long	O
fragment	O
of	O
the	O
Fgf21	B-GP
promoter	O
was	O
linked	O
to	O
a	O
luciferase	B-GP
reporter	O
gene	O
(	O
Fgf21	B-GP
::	O
luc	B-GP
)	O
and	O
transfected	O
into	O
NIH	O
3T3	O
cells	O
along	O
with	O
increasing	O
amounts	O
of	O
Bmal1	B-GP
and	O
Clock	B-GP
expression	O
vectors	O
(	O
Fig	O
.	O
2A	O
).	O

As	O
expected	O
,	O
BMAL1	B-GP
/	O
CLOCK	B-GP
induced	O
the	O
Per1	B-GP
::	O
luc	B-GP
control	O
reporter	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

In	O
contrast	O
,	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
was	O
not	O
induced	O
,	O
indicating	O
that	O
BMAL1	B-GP
and	O
CLOCK	B-GP
are	O
not	O
regulating	O
the	O
Fgf21	B-GP
promoter	O
and	O
hence	O
are	O
probably	O
not	O
directly	O
responsible	O
for	O
the	O
diurnal	O
expression	O
of	O
Fgf21	B-GP
mRNA	O
observed	O
in	O
Fig	O
.	O
1D	O
.	O

Since	O
BMAL1	B-GP
and	O
CLOCK	B-GP
activate	O
not	O
only	O
Rev	B-GP
-	I-GP
erbα	I-GP
but	O
also	O
Pparα	B-GP
(	O
Canaple	O
et	O
al	O
.,	O
2006	O
),	O
the	O
expected	O
repression	O
of	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
is	O
probably	O
compensated	O
by	O
the	O
activating	O
potential	O
of	O
PPARα	B-GP
(	O
Inagaki	O
et	O
al	O
.,	O
2007	O
).	O
Fig	O
.	O
2	O
.	O
Regulation	O
of	O
the	O
Fgf21	B-GP
promoter	O
by	O
clock	B-GP
components	O
.	O
(	O
A	O
)	O
Dose	O
-	O
dependent	O
activation	O
of	O
the	O
Per1	B-GP
::	O
luc	B-GP
promoter	O
by	O
BMAL1	B-GP
and	O
CLOCK	B-GP
(	O
black	O
bars	O
)	O
and	O
no	O
BMAL1	B-GP
/	O
CLOCK	B-GP
activation	O
of	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
white	O
bars	O
)	O
in	O
NIH3T3	O
cells	O
(	O
n	O
=	O
3	O
).	O

(	O
B	O
)	O
Dose	O
dependent	O
repression	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
on	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
(	O
black	O
bars	O
)	O
and	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
white	O
bars	O
)	O
in	O
NIH3T3	O
cells	O
(	O
n	O
=	O
4	O
).	O

(	O
C	O
)	O
Mutation	O
analysis	O
of	O
the	O
Fgf21	B-GP
promoter	O
.	O

Top	O
left	O
:	O
schematic	O
diagram	O
showing	O
the	O
positions	O
of	O
the	O
four	O
ROREs	O
(	O
R1	O
-	O
R4	O
),	O
the	O
PPAR	B-GP
element	O
(	O
blue	O
)	O
and	O
the	O
HNF6	B-GP
binding	O
site	O
(	O
green	O
).	O

Top	O
right	O
:	O
diagram	O
of	O
the	O
mutations	O
in	O
R1	O
and	O
R4	O
,	O
respectively	O
.	O

Bottom	O
:	O
panels	O
of	O
fold	O
change	O
of	O
the	O
various	O
constructs	O
.	O

Black	O
bars	O
:	O
reference	O
value	O
for	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
and	O
Fgf21	B-GP
::	O
luc	B-GP
reporters	O
,	O
respectively	O
.	O

White	O
bars	O
:	O
relative	O
repression	O
by	O
Rev	B-GP
-	I-GP
erbα	I-GP
.	O

Hatched	O
bars	O
:	O
reduced	O
repression	O
by	O
Rev	B-GP
-	I-GP
erbα	I-GP
on	O
the	O
mutated	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
n	O
=	O
4	O
).	O

(	O
D	O
)	O
Dose	O
-	O
dependent	O
activating	O
potential	O
of	O
RORα	B-GP
on	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
(	O
black	O
bars	O
)	O
but	O
not	O
on	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
white	O
bars	O
)	O
in	O
NIH3T3	O
cells	O
(	O
n	O
=	O
3	O
).	O

(	O
E	O
)	O
Repression	O
of	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
(	O
white	O
bars	O
)	O
and	O
Fgf21	B-GP
::	O
luc	B-GP
(	O
blue	O
bars	O
)	O
reporters	O
in	O
Hepa	O
-	O
1c1c7	O
cells	O
involves	O
Hnf6	B-GP
.	O

Sc	O
shRNA	O
,	O
scrambled	O
shRNA	O
;	O
Hnf6	B-GP
shRNA	O
,	O
knockdown	O
of	O
Hnf6	B-GP
(	O
n	O
=	O
3	O
).	O

(	O
F	O
)	O
Repressive	O
potential	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
in	O
Hepa	O
-	O
1c1c7	O
cells	O
on	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
,	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
and	O
the	O
Hnf6	B-GP
site	O
mutated	O
Fgf21	B-GP
::	O
luc	B-GP
(	O
mut	O
Fgf21	B-GP
::	O
luc	B-GP
)	O
reporters	O
(	O
n	O
=	O
3	O
).	O

(	O
G	O
)	O
Fold	O
induction	O
of	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
by	O
Pparα	B-GP
,	O
Rxrα	B-GP
and	O
Per2	B-GP
in	O
NIH3T3	O
cells	O
(	O
n	O
=	O
4	O
).	O

All	O
panels	O
:	O
one	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
test	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
,	O
values	O
are	O
means	O
±	O
s	O
.	O
d	O
.	O

We	O
tested	O
the	O
repressive	O
potential	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
on	O
the	O
3	O
.	O
1	O
kB	O
Fgf21	B-GP
promoter	O
,	O
containing	O
four	O
ROREs	O
and	O
one	O
PPARE	O
,	O
designated	O
as	O
R1	O
-	O
R4	O
and	O
P	O
in	O
Fig	O
.	O
2C	O
,	O
respectively	O
.	O

REV	B-GP
-	I-GP
ERBα	I-GP
repressed	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
as	O
expected	O
,	O
and	O
also	O
repressed	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
Fig	O
.	O
2B	O
)	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Mutation	O
of	O
the	O
R1	O
element	O
in	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
reduced	O
the	O
repressive	O
potential	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Fig	O
.	O
2C	O
),	O
which	O
is	O
consistent	O
with	O
previous	O
findings	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
may	O
repress	O
Fgf21	B-GP
expression	O
via	O
this	O
RORE	O
site	O
(	O
Estall	O
et	O
al	O
.,	O
2009	O
).	O

Interestingly	O
,	O
however	O
,	O
the	O
repression	O
was	O
not	O
completely	O
reversed	O
by	O
the	O
mutation	O
of	O
R1	O
,	O
suggesting	O
that	O
additional	O
promoter	O
elements	O
are	O
most	O
likely	O
involved	O
in	O
the	O
REV	B-GP
-	I-GP
ERBα	I-GP
-	O
mediated	O
repression	O
of	O
Fgf21	B-GP
.	O

Therefore	O
,	O
we	O
tested	O
the	O
R2	O
and	O
R3	O
elements	O
as	O
potential	O
REV	B-GP
-	I-GP
ERBα	I-GP
binding	O
sites	O
,	O
but	O
no	O
repression	O
through	O
these	O
two	O
sites	O
was	O
observed	O
(	O
Fig	O
.	O
2C	O
).	O

In	O
contrast	O
,	O
the	O
R4	O
element	O
appeared	O
to	O
be	O
involved	O
in	O
the	O
repression	O
of	O
Fgf21	B-GP
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
as	O
mutation	O
of	O
this	O
element	O
partially	O
abolished	O
the	O
repressive	O
potential	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Fig	O
.	O
2C	O
).	O

Hence	O
,	O
the	O
ROREs	O
R1	O
and	O
R4	O
may	O
be	O
the	O
sites	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
binding	O
at	O
the	O
Fgf21	B-GP
promoter	O
,	O
regulating	O
its	O
expression	O
.	O

Since	O
the	O
classical	O
mechanism	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
-	O
mediated	O
repression	O
involves	O
competition	O
with	O
the	O
transcriptional	O
activator	O
RORα	B-GP
,	O
we	O
tested	O
whether	O
RORα	B-GP
activates	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
construct	O
.	O

As	O
expected	O
,	O
RORα	B-GP
could	O
activate	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
(	O
Fig	O
.	O
2D	O
),	O
however	O
,	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
did	O
not	O
or	O
only	O
poorly	O
respond	O
to	O
RORα	B-GP
(	O
Fig	O
.	O
2D	O
).	O

Therefore	O
,	O
we	O
suspected	O
that	O
Fgf21	B-GP
is	O
indirectly	O
regulated	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
via	O
hepatic	B-GP
nuclear	I-GP
factor	I-GP
6	I-GP
(	O
HNF6	B-GP
),	O
a	O
second	O
mechanism	O
through	O
which	O
REV	B-GP
-	I-GP
ERBα	I-GP
can	O
act	O
(	O
Zhang	O
et	O
al	O
.,	O
2015	O
)	O
(	O
see	O
also	O
the	O
presence	O
of	O
an	O
HNF6	B-GP
binding	O
site	O
H	O
in	O
Fig	O
.	O
2C	O
).	O

Transactivation	O
experiments	O
in	O
Hepa	O
-	O
1c1c7	O
cells	O
revealed	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
suppresses	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
in	O
an	O
HNF6	B-GP
independent	O
manner	O
,	O
because	O
Hnf6	B-GP
shRNA	O
did	O
not	O
affect	O
this	O
repression	O
(	O
Fig	O
.	O
2E	O
);	O
although	O
Hnf6	B-GP
mRNA	O
and	O
protein	O
was	O
strongly	O
repressed	O
with	O
Rev	B-GP
-	I-GP
erbα	I-GP
expression	O
unaffected	O
(	O
Fig	O
.	O
S1	O
).	O

Interestingly	O
,	O
Hnf6	B-GP
shRNA	O
induced	O
Fgf21	B-GP
mRNA	O
expression	O
,	O
indicating	O
that	O
HNF6	B-GP
is	O
mediating	O
a	O
repressing	O
activity	O
on	O
the	O
Fgf21	B-GP
promoter	O
(	O
Fig	O
.	O
S1	O
).	O

Therefore	O
,	O
we	O
tested	O
the	O
influence	O
of	O
HNF6	B-GP
on	O
the	O
REV	B-GP
-	I-GP
ERBα	I-GP
repressive	O
function	O
of	O
the	O
Fgf21	B-GP
promoter	O
observed	O
in	O
Fig	O
.	O
2B	O
.	O

We	O
found	O
that	O
Hnf6	B-GP
shRNA	O
,	O
but	O
not	O
scrambled	O
shRNA	O
,	O
increased	O
the	O
luciferase	B-GP
activity	O
in	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
,	O
suggesting	O
that	O
HNF6	B-GP
is	O
a	O
direct	O
modulator	O
of	O
this	O
promoter	O
,	O
and	O
the	O
lack	O
of	O
it	O
increases	O
baseline	O
expression	O
of	O
Fgf21	B-GP
.	O

Accordingly	O
,	O
the	O
repression	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
on	O
this	O
promoter	O
only	O
partially	O
repressed	O
activation	O
and	O
in	O
absence	O
of	O
HNF6	B-GP
,	O
REV	B-GP
-	I-GP
ERBα	I-GP
alone	O
did	O
not	O
repress	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
below	O
baseline	O
levels	O
(	O
Fig	O
.	O
2E	O
).	O

This	O
suggests	O
that	O
repression	O
of	O
the	O
Fgf21	B-GP
promoter	O
is	O
most	O
likely	O
the	O
result	O
of	O
cooperation	O
between	O
HNF6	B-GP
and	O
REV	B-GP
-	I-GP
ERBα	I-GP
.	O

Interestingly	O
,	O
there	O
is	O
an	O
HNF6	B-GP
binding	O
site	O
(	O
Zhang	O
et	O
al	O
.,	O
2015	O
)	O
close	O
to	O
the	O
RORE	O
designated	O
as	O
R1	O
in	O
Fig	O
.	O
2C	O
.	O

Mutating	O
this	O
HNF6	B-GP
binding	O
site	O
abolished	O
REV	B-GP
-	I-GP
ERBα	I-GP
mediated	O
repression	O
of	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
Fig	O
.	O
2F	O
),	O
indicating	O
that	O
repression	O
of	O
this	O
reporter	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
requires	O
the	O
binding	O
of	O
HNF6	B-GP
.	O

Because	O
we	O
identified	O
a	O
PPAR	B-GP
binding	O
site	O
(	O
P	O
in	O
Fig	O
.	O
2C	O
)	O
between	O
the	O
RORE	O
R1	O
and	O
R2	O
,	O
we	O
tested	O
whether	O
PPARα	B-GP
,	O
together	O
with	O
its	O
heterodimerizing	O
partner	O
RXRα	B-GP
,	O
may	O
modulate	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
.	O

We	O
observed	O
that	O
PPARα	B-GP
activated	O
this	O
reporter	O
and	O
combined	O
with	O
RXRα	B-GP
this	O
induction	O
was	O
even	O
greater	O
(	O
Fig	O
.	O
2G	O
).	O

Addition	O
of	O
Per2	B-GP
increased	O
this	O
activation	O
further	O
(	O
Fig	O
.	O
2G	O
),	O
indicating	O
that	O
PPARα	B-GP
,	O
RXRα	B-GP
and	O
Per2	B-GP
have	O
an	O
activating	O
function	O
on	O
the	O
Fgf21	B-GP
promoter	O
.	O

Binding	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
HNF6	B-GP
and	O
PPARα	B-GP
to	O
the	O
Fgf21	B-GP
promoter	O
in	O
liver	O

In	O
order	O
to	O
test	O
whether	O
the	O
regulation	O
of	O
the	O
Fgf21	B-GP
promoter	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
HNF6	B-GP
and	O
PPARα	B-GP
can	O
occur	O
in	O
liver	O
tissue	O
,	O
we	O
performed	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
experiments	O
.	O

Chromatin	O
from	O
livers	O
of	O
female	O
mice	B-OG
was	O
isolated	O
and	O
antibodies	B-GP
against	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
HNF6	B-GP
and	O
PPARα	B-GP
were	O
used	O
to	O
identify	O
the	O
promoter	O
sequences	O
in	O
Fgf21	B-GP
bound	O
by	O
these	O
transcription	B-GP
factors	I-GP
.	O

We	O
tested	O
the	O
four	O
RORE	O
-	O
containing	O
regions	O
(	O
R1	O
-	O
R4	O
)	O
in	O
the	O
Fgf21	B-GP
promoter	O
for	O
binding	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Fig	O
.	O
3A	O
).	O

We	O
observed	O
the	O
strongest	O
binding	O
to	O
the	O
R1	O
element	O
(	O
which	O
included	O
also	O
the	O
HNF6	B-GP
site	O
)	O
with	O
weaker	O
binding	O
to	O
the	O
R4	O
element	O
and	O
no	O
binding	O
to	O
the	O
R2	O
and	O
R3	O
elements	O
.	O

Interestingly	O
,	O
the	O
binding	O
to	O
R1	O
and	O
R4	O
was	O
time	O
-	O
of	O
-	O
day	O
dependent	O
with	O
more	O
REV	B-GP
-	I-GP
ERBα	I-GP
binding	O
at	O
ZT10	O
than	O
ZT22	O
(	O
Fig	O
.	O
3A	O
),	O
which	O
is	O
consistent	O
with	O
the	O
expression	O
pattern	O
of	O
Fgf21	B-GP
(	O
Fig	O
.	O
1D	O
,	O
E	O
).	O

The	O
pattern	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
binding	O
was	O
similar	O
compared	O
to	O
the	O
Bmal1	B-GP
and	O
Rev	B-GP
-	I-GP
erbα	I-GP
promoter	O
controls	O
(	O
Fig	O
.	O
3A	O
).	O

In	O
contrast	O
,	O
binding	O
of	O
HNF6	B-GP
to	O
the	O
Fgf21	B-GP
promoter	O
was	O
not	O
time	O
-	O
of	O
-	O
day	O
dependent	O
and	O
only	O
occurred	O
in	O
the	O
R1	O
element	O
,	O
which	O
includes	O
the	O
HNF6	B-GP
binding	O
site	O
.	O

R2	O
,	O
R3	O
and	O
R4	O
did	O
not	O
show	O
HNF6	B-GP
binding	O
(	O
Fig	O
.	O
3B	O
).	O

Similar	O
to	O
HNF6	B-GP
,	O
PPARα	B-GP
binding	O
to	O
the	O
Fgf21	B-GP
promoter	O
was	O
not	O
time	O
-	O
of	O
-	O
day	O
dependent	O
,	O
with	O
strong	O
binding	O
at	O
both	O
ZT8	O
and	O
ZT20	O
in	O
both	O
wild	O
-	O
type	O
and	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
(	O
Fig	O
.	O
3C	O
).	O

Interestingly	O
,	O
PPARα	B-GP
binding	O
to	O
the	O
Bmal1	B-GP
promoter	O
was	O
time	O
-	O
of	O
-	O
day	O
dependent	O
(	O
Fig	O
.	O
3C	O
),	O
indicating	O
that	O
the	O
mechanism	O
of	O
regulation	O
by	O
PPARα	B-GP
of	O
the	O
Fgf21	B-GP
promoter	O
is	O
different	O
from	O
the	O
regulation	O
of	O
the	O
Bmal1	B-GP
promoter	O
.	O
Fig	O
.	O
3	O
.	O
Chromatin	O
immunoprecipitation	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
HNF6	B-GP
,	O
PPARα	B-GP
and	O
PER2	B-GP
on	O
the	O
Fgf21	B-GP
promoter	O
of	O
liver	O
chromatin	O
.	O
(	O
A	O
)	O
Binding	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
to	O
its	O
own	O
promoter	O
and	O
to	O
the	O
Bmal1	B-GP
and	O
Fgf21	B-GP
promoters	O
at	O
Zeitgeber	O
time	O
(	O
ZT	O
)	O
10	O
(	O
black	O
bars	O
)	O
and	O
ZT22	O
(	O
white	O
bars	O
),	O
respectively	O
.	O

(	O
B	O
)	O
Binding	O
of	O
HNF6	B-GP
to	O
the	O
R1	O
-	O
R4	O
elements	O
on	O
the	O
Fgf21	B-GP
promoter	O
at	O
ZT10	O
and	O
ZT22	O
.	O

(	O
C	O
)	O
Binding	O
of	O
PPARα	B-GP
on	O
the	O
Bmal1	B-GP
and	O
Fgf21	B-GP
promoters	O
in	O
the	O
liver	O
of	O
wild	O
-	O
type	O
(	O
black	O
bars	O
)	O
and	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
bars	O
)	O
animals	B-OG
at	O
ZT8	O
and	O
ZT20	O
.	O

(	O
D	O
)	O
Binding	O
of	O
PER2	B-GP
on	O
the	O
Bmal1	B-GP
and	O
Fgf21	B-GP
promoters	O
in	O
the	O
liver	O
of	O
wild	O
-	O
type	O
(	O
black	O
bars	O
)	O
and	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
(	O
red	O
bars	O
)	O
animals	B-OG
at	O
ZT8	O
and	O
ZT20	O
.	O

All	O
panels	O
:	O
two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
test	O
,	O
n	O
=	O
3	O
,	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
;	O
values	O
are	O
means	O
±	O
s	O
.	O
e	O
.	O
m	O
.	O

Because	O
PER2	B-GP
can	O
bind	O
to	O
both	O
REV	B-GP
-	I-GP
ERBα	I-GP
and	O
PPARα	B-GP
(	O
Schmutz	O
et	O
al	O
.,	O
2010	O
),	O
we	O
tested	O
PER2	B-GP
binding	O
to	O
the	O
Fgf21	B-GP
promoter	O
.	O

We	O
observed	O
that	O
PER2	B-GP
binds	O
in	O
a	O
time	O
-	O
of	O
-	O
day	O
dependent	O
manner	O
to	O
both	O
the	O
Bmal1	B-GP
and	O
Fgf21	B-GP
promoters	O
in	O
wild	O
-	O
type	O
mice	B-OG
,	O
however	O
,	O
only	O
to	O
the	O
Bmal1	B-GP
promoter	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
animals	B-OG
(	O
Fig	O
.	O
3C	O
).	O

This	O
indicates	O
that	O
binding	O
of	O
PER2	B-GP
to	O
the	O
Fgf21	B-GP
promoter	O
depends	O
on	O
the	O
presence	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
and	O
/	O
or	O
PPARα	B-GP
.	O

DISCUSSION	O

There	O
is	O
strong	O
evidence	O
that	O
the	O
circadian	O
clock	B-GP
influences	O
fertility	O
and	O
therefore	O
reproductive	O
fitness	O
in	O
mice	B-OG
(	O
Miller	O
and	O
Takahashi	O
,	O
2013	O
;	O
Sellix	O
and	O
Menaker	O
,	O
2010	O
).	O

We	O
observed	O
that	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
produce	O
less	O
pups	O
and	O
have	O
less	O
litters	O
associated	O
with	O
a	O
longer	O
inter	O
-	O
litter	O
period	O
(	O
Fig	O
.	O
1A	O
-	O
C	O
);	O
however	O
,	O
the	O
mechanisms	O
linking	O
the	O
clock	B-GP
with	O
reproduction	O
are	O
not	O
well	O
understood	O
.	O

We	O
provide	O
evidence	O
that	O
FGF21	B-GP
,	O
which	O
regulates	O
metabolism	O
(	O
reviewed	O
in	O
Nies	O
et	O
al	O
.,	O
2016	O
)	O
and	O
modulates	O
fertility	O
(	O
Owen	O
et	O
al	O
.,	O
2013	O
),	O
may	O
be	O
one	O
of	O
the	O
links	O
.	O

Animals	B-OG
overexpressing	O
FGF21	B-GP
show	O
reduced	O
fertility	O
,	O
which	O
is	O
similar	O
to	O
the	O
phenotype	O
of	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
animals	B-OG
.	O

This	O
similarity	O
is	O
further	O
highlighted	O
by	O
our	O
finding	O
that	O
expression	O
of	O
Fgf21	B-GP
mRNA	O
,	O
as	O
well	O
as	O
FGF21	B-GP
protein	O
,	O
is	O
elevated	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
mice	B-OG
(	O
Fig	O
.	O
1D	O
,	O
E	O
).	O

Hence	O
,	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
animals	B-OG
can	O
be	O
considered	O
as	O
Fgf21	B-GP
overexpressors	O
,	O
although	O
they	O
overexpress	O
Fgf21	B-GP
to	O
a	O
much	O
lesser	O
extent	O
compared	O
to	O
the	O
transgenic	O
mice	B-OG
described	O
by	O
Owen	O
et	O
al	O
.	O
(	O
2013	O
).	O

The	O
diurnal	O
cycling	O
of	O
Fgf21	B-GP
mRNA	O
in	O
wild	O
-	O
type	O
liver	O
(	O
Fig	O
.	O
1D	O
)	O
is	O
similar	O
to	O
the	O
diurnal	O
expression	O
of	O
Bmal1	B-GP
,	O
indicating	O
that	O
BMAL1	B-GP
/	O
CLOCK	B-GP
are	O
most	O
likely	O
not	O
responsible	O
for	O
Fgf21	B-GP
cycling	O
,	O
despite	O
a	O
previous	O
report	O
that	O
described	O
BMAL1	B-GP
/	O
CLOCK	B-GP
-	O
mediated	O
activation	O
of	O
a	O
2	O
kb	O
long	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
Tong	O
et	O
al	O
.,	O
2010	O
).	O

Our	O
own	O
experiments	O
indicate	O
that	O
our	O
3	O
.	O
1	O
kb	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
is	O
not	O
activated	O
by	O
BMAL1	B-GP
/	O
CLOCK	B-GP
(	O
Fig	O
.	O
2A	O
).	O

Interestingly	O
,	O
ChIP	O
-	O
sequencing	O
experiments	O
revealed	O
BMAL1	B-GP
binding	O
to	O
the	O
Fgf21	B-GP
promoter	O
,	O
however	O
no	O
evidence	O
of	O
binding	O
for	O
CLOCK	B-GP
or	O
NPAS2	B-GP
was	O
found	O
(	O
Koike	O
et	O
al	O
.,	O
2012	O
).	O

This	O
indicates	O
that	O
the	O
Fgf21	B-GP
promoter	O
is	O
most	O
likely	O
not	O
activated	O
by	O
BMAL1	B-GP
/	O
CLOCK	B-GP
or	O
BMAL1	B-GP
/	O
NPAS2	B-GP
heterodimers	O
in	O
vivo	O
.	O

What	O
the	O
role	O
of	O
BMAL1	B-GP
binding	O
to	O
the	O
Fgf21	B-GP
promoter	O
is	O
and	O
whether	O
it	O
has	O
activating	O
potential	O
with	O
an	O
unknown	O
heterodimerization	O
partner	O
remains	O
to	O
be	O
determined	O
.	O

Because	O
Fgf21	B-GP
expression	O
in	O
liver	O
is	O
increased	O
in	O
Rev	B-GP
-	I-GP
erbα	I-GP
−/−	O
animals	B-OG
(	O
Fig	O
.	O
1D	O
),	O
reminiscent	O
of	O
the	O
increased	O
expression	O
of	O
Bmal1	B-GP
(	O
Preitner	O
et	O
al	O
.,	O
2002	O
),	O
we	O
tested	O
whether	O
the	O
Fgf21	B-GP
promoter	O
could	O
be	O
repressed	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
.	O

We	O
found	O
that	O
Fgf21	B-GP
was	O
repressed	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
in	O
a	O
dose	O
dependent	O
manner	O
,	O
comparable	O
to	O
the	O
Bmal1	B-GP
promoter	O
(	O
Fig	O
.	O
2B	O
).	O

This	O
is	O
in	O
line	O
with	O
previous	O
findings	O
that	O
suggested	O
repression	O
of	O
the	O
Fgf21	B-GP
promoter	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Estall	O
et	O
al	O
.,	O
2009	O
).	O

Interestingly	O
,	O
the	O
reported	O
RORE	O
in	O
that	O
work	O
(	O
R1	O
in	O
Fig	O
.	O
2	O
)	O
is	O
not	O
the	O
only	O
RORE	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
Fgf21	B-GP
promoter	O
as	O
revealed	O
by	O
our	O
mutation	O
studies	O
(	O
Fig	O
.	O
2C	O
).	O

It	O
appears	O
that	O
at	O
least	O
another	O
RORE	O
(	O
R4	O
in	O
Fig	O
.	O
2	O
)	O
is	O
involved	O
in	O
REV	B-GP
-	I-GP
ERBα	I-GP
-	O
mediated	O
repression	O
of	O
the	O
Fgf21	B-GP
promoter	O
.	O

If	O
REV	B-GP
-	I-GP
ERBα	I-GP
regulates	O
Fgf21	B-GP
via	O
direct	O
binding	O
to	O
the	O
RORE	O
it	O
would	O
compete	O
with	O
RORα	B-GP
for	O
this	O
binding	O
site	O
.	O

Therefore	O
,	O
we	O
tested	O
whether	O
RORα	B-GP
induces	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
as	O
it	O
does	O
for	O
the	O
Bmal1	B-GP
::	O
luc	B-GP
reporter	O
.	O

We	O
found	O
no	O
dose	O
-	O
dependent	O
action	O
of	O
RORα	B-GP
on	O
the	O
Fgf21	B-GP
promoter	O
,	O
in	O
contrast	O
to	O
previous	O
reports	O
that	O
suggested	O
an	O
involvement	O
of	O
RORα	B-GP
in	O
Fgf21	B-GP
regulation	O
(	O
Wang	O
et	O
al	O
.,	O
2010	O
).	O

Of	O
note	O
is	O
that	O
no	O
dose	O
response	O
curve	O
for	O
RORα	B-GP
was	O
established	O
in	O
that	O
study	O
,	O
which	O
may	O
lead	O
to	O
a	O
misinterpretation	O
of	O
data	O
.	O

A	O
recent	O
study	O
identified	O
nobiletin	O
as	O
an	O
agonist	O
of	O
ROR	B-GP
nuclear	I-GP
receptors	I-GP
.	O

Application	O
of	O
nobiletin	O
increased	O
expression	O
of	O
ROR	B-GP
target	O
genes	O
in	O
the	O
liver	O
involved	O
in	O
metabolism	O
,	O
with	O
Fgf21	B-GP
being	O
unaffected	O
(	O
He	O
et	O
al	O
.,	O
2016	O
).	O

This	O
supports	O
our	O
observation	O
that	O
RORα	B-GP
is	O
not	O
involved	O
in	O
the	O
regulation	O
of	O
Fgf21	B-GP
expression	O
in	O
the	O
liver	O
.	O

From	O
our	O
data	O
we	O
conclude	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
may	O
act	O
on	O
the	O
Fgf21	B-GP
promoter	O
via	O
another	O
mechanism	O
,	O
different	O
from	O
the	O
competition	O
mechanism	O
between	O
REV	B-GP
-	I-GP
ERBα	I-GP
and	O
RORα	B-GP
.	O

A	O
recent	O
study	O
identified	O
a	O
second	O
mode	O
of	O
action	O
for	O
REV	B-GP
-	I-GP
ERBα	I-GP
in	O
the	O
liver	O
.	O

Whereas	O
the	O
direct	O
competition	O
mechanism	O
between	O
REV	B-GP
-	I-GP
ERBα	I-GP
and	O
ROR	B-GP
transcription	B-GP
factors	I-GP
provides	O
a	O
universal	O
mechanism	O
for	O
self	O
-	O
sustained	O
control	O
of	O
the	O
molecular	O
clock	B-GP
across	O
all	O
tissues	O
,	O
REV	B-GP
-	I-GP
ERBα	I-GP
uses	O
lineage	O
-	O
determining	O
factors	O
to	O
convey	O
a	O
tissue	O
-	O
specific	O
rhythm	O
that	O
regulates	O
metabolism	O
tailored	O
to	O
the	O
specific	O
need	O
of	O
that	O
tissue	O
(	O
Zhang	O
et	O
al	O
.,	O
2015	O
).	O

In	O
the	O
liver	O
,	O
the	O
tissue	O
-	O
specific	O
factor	O
is	O
HNF6	B-GP
through	O
which	O
REV	B-GP
-	I-GP
ERBα	I-GP
can	O
modulate	O
gene	O
expression	O
in	O
an	O
HNF6	B-GP
-	O
dependent	O
fashion	O
.	O

In	O
accordance	O
with	O
this	O
hypothesis	O
,	O
we	O
found	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
regulates	O
Fgf21	B-GP
expression	O
involving	O
HNF6	B-GP
(	O
Figs	O
2E	O
,	O
F	O
,	O
3B	O
and	O
Fig	O
.	O
S1	O
).	O

This	O
concept	O
is	O
also	O
consistent	O
with	O
the	O
observation	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
can	O
regulate	O
FGF21	B-GP
signaling	O
in	O
an	O
adipose	O
tissue	O
-	O
specific	O
manner	O
by	O
directly	O
regulating	O
βKlotho	B-GP
,	O
an	O
essential	O
co	O
-	O
receptor	O
for	O
FGF21	B-GP
signaling	O
(	O
Jager	O
et	O
al	O
.,	O
2016	O
).	O

In	O
addition	O
to	O
HNF6	B-GP
binding	O
sites	O
(	O
Fig	O
.	O
3B	O
),	O
we	O
found	O
PPAR	B-GP
elements	O
in	O
the	O
Fgf21	B-GP
promoter	O
sequence	O
(	O
Figs	O
2G	O
and	O
3C	O
).	O

We	O
could	O
confirm	O
that	O
PPARα	B-GP
regulates	O
expression	O
of	O
Fgf21	B-GP
(	O
Figs	O
2G	O
and	O
3C	O
)	O
as	O
described	O
previously	O
(	O
Oishi	O
et	O
al	O
.,	O
2008	O
).	O

Furthermore	O
,	O
we	O
observed	O
that	O
PER2	B-GP
can	O
increase	O
induction	O
of	O
the	O
Fgf21	B-GP
::	O
luc	B-GP
reporter	O
(	O
Fig	O
.	O
2G	O
).	O

This	O
increase	O
may	O
be	O
partially	O
mediated	O
by	O
binding	O
of	O
PER2	B-GP
to	O
PPARα	B-GP
,	O
but	O
lack	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
abolishes	O
binding	O
of	O
PER2	B-GP
to	O
the	O
Fgf21	B-GP
promoter	O
of	O
liver	O
chromatin	O
(	O
Fig	O
.	O
3D	O
),	O
suggesting	O
a	O
complex	O
regulation	O
of	O
the	O
Fgf21	B-GP
promoter	O
by	O
PPARα	B-GP
and	O
REV	B-GP
-	I-GP
ERBα	I-GP
with	O
PER2	B-GP
modulating	O
the	O
transcriptional	O
potential	O
of	O
both	O
of	O
these	O
nuclear	O
receptors	O
.	O

This	O
is	O
consistent	O
with	O
previous	O
observations	O
reporting	O
that	O
PER2	B-GP
is	O
binding	O
to	O
both	O
PPARα	B-GP
and	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Schmutz	O
et	O
al	O
.,	O
2010	O
).	O

Hence	O
,	O
PER2	B-GP
may	O
mediate	O
the	O
formation	O
of	O
a	O
time	O
-	O
of	O
-	O
day	O
dependent	O
super	O
complex	O
containing	O
PPARα	B-GP
and	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
most	O
likely	O
along	O
with	O
additional	O
co	O
-	O
factors	O
.	O

Taken	O
together	O
,	O
we	O
present	O
evidence	O
that	O
REV	B-GP
-	I-GP
ERBα	I-GP
regulates	O
Fgf21	B-GP
expression	O
in	O
the	O
liver	O
involving	O
HNF6	B-GP
.	O

This	O
mechanism	O
may	O
be	O
influenced	O
by	O
PER2	B-GP
and	O
PPARα	B-GP
(	O
Fig	O
.	O
4	O
).	O

Since	O
FGF21	B-GP
is	O
released	O
from	O
the	O
liver	O
into	O
the	O
bloodstream	O
to	O
reach	O
the	O
brain	O
influencing	O
fertility	O
via	O
the	O
hypothalamus	O
,	O
REV	B-GP
-	I-GP
ERBα	I-GP
may	O
modulate	O
fertility	O
via	O
this	O
pathway	O
.	O

However	O
,	O
the	O
contribution	O
of	O
REV	B-GP
-	I-GP
ERBα	I-GP
to	O
reproductive	O
fitness	O
is	O
most	O
likely	O
not	O
limited	O
to	O
Fgf21	B-GP
regulation	O
,	O
but	O
may	O
also	O
include	O
additional	O
processes	O
,	O
such	O
as	O
the	O
regulation	O
of	O
ovarian	O
biology	O
and	O
metabolic	O
pathways	O
known	O
to	O
be	O
regulated	O
by	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
Bugge	O
et	O
al	O
.,	O
2012	O
;	O
Cho	O
et	O
al	O
.,	O
2012	O
),	O
thereby	O
affecting	O
fertility	O
in	O
an	O
indirect	O
manner	O
.	O
Fig	O
.	O
4	O
.	O
Schematic	O
representing	O
clock	B-GP
contribution	O
to	O
Fgf21	B-GP
regulation	O
in	O
the	O
liver	O
.	O
REV	B-GP
-	I-GP
ERBα	I-GP
(	O
R	O
orange	O
circle	O
)	O
represses	O
the	O
Fgf21	B-GP
promoter	O
involving	O
HNF6	B-GP
(	O
olive	O
trapezoid	O
).	O

Furthermore	O
,	O
PPARα	B-GP
(	O
green	O
oval	O
)	O
with	O
its	O
heterodimerizing	O
partner	O
RXR	B-GP
(	O
light	O
blue	O
oval	O
)	O
activates	O
the	O
Fgf21	B-GP
promoter	O
.	O

PER2	B-GP
(	O
P2	O
,	O
red	O
circle	O
)	O
most	O
likely	O
modulates	O
one	O
or	O
both	O
of	O
these	O
regulations	O
due	O
to	O
its	O
capacity	O
to	O
bind	O
to	O
PPARα	B-GP
and	O
REV	B-GP
-	I-GP
ERBα	I-GP
.	O

Our	O
data	O
indicate	O
that	O
BMAL1	B-GP
(	O
B	O
blue	O
circle	O
)	O
and	O
CLOCK	B-GP
(	O
C	O
/	O
N	O
purple	O
oval	O
)	O
are	O
not	O
significantly	O
involved	O
in	O
the	O
regulation	O
of	O
Fgf21	B-GP
.	O

MATERIALS	O
AND	O
METHODS	O

Animals	B-OG

Animal	B-OG
care	O
and	O
handling	O
were	O
performed	O
in	O
accordance	O
with	O
the	O
guidelines	O
of	O
the	O
Schweizer	O
Tierschutzgesetz	O
(	O
TSchG	O
,	O
SR455	O
)	O
and	O
the	O
Declaration	O
of	O
Helsinki	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
state	O
veterinarian	O
of	O
the	O
Canton	O
of	O
Fribourg	O
.	O
Rev	B-GP
-	I-GP
Erbα	I-GP
−/−	O
mice	B-OG
were	O
obtained	O
from	O
Dr	O
U	O
.	O

Schibler	O
(	O
University	O
of	O
Geneva	O
,	O
Switzerland	O
)	O
and	O
are	O
on	O
a	O
mixed	O
background	O
129Sv	O
/	O
C57BL6	O
(	O
Preitner	O
et	O
al	O
.,	O
2002	O
).	O

Animals	B-OG
were	O
maintained	O
on	O
12	O
h	O
light	O
:	O
12	O
h	O
dark	O
cycle	O
with	O
food	O
and	O
water	O
ad	O
libitum	O
.	O

Cell	O
culture	O
and	O
luciferase	B-GP
assay	O

NIH3T3	O
and	O
Hepa	O
-	O
1c1c7	O
mouse	B-OG
cells	O
were	O
used	O
for	O
in	O
vitro	O
experiments	O
.	O

Cells	O
were	O
maintained	O
in	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
(	O
DMEM	O
),	O
high	O
glucose	O
(	O
4	O
.	O
5	O
g	O
/	O
l	O
)	O
(	O
6429	O
,	O
Sigma	O
,	O
USA	O
)	O
containing	O
10	O
%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
and	O
100	O
U	O
/	O
ml	O
penicillin	O
/	O
streptomycin	O
at	O
37	O
°	O
C	O
in	O
a	O
humidified	O
atmosphere	O
containing	O
5	O
%	O
CO2	O
.	O

Expression	O
plasmids	O
pSCT1	O
-	O
PPARα	B-GP
,	O
pSCT1	O
-	O
RXRα	B-GP
,	O
pSCT1	O
-	O
PER2	B-GP
,	O
pSCT1	O
-	O
LacZ	B-GP
(	O
β	B-GP
-	I-GP
galactosidase	I-GP
),	O
pSCT1	O
-	O
REV	B-GP
-	I-GP
ERBα	I-GP
,	O
pSCT1	O
-	O
RORα	B-GP
and	O
Bmal1	B-GP
luciferase	B-GP
construct	O
(	O
with	O
PPAR	B-GP
regulatory	O
site	O
)	O
are	O
described	O
(	O
Schmutz	O
et	O
al	O
.,	O
2010	O
).	O

Mouse	B-OG
Fgf21	B-GP
promoter	O
is	O
harboring	O
four	O
putative	O
retinoid	B-GP
orphan	I-GP
receptor	I-GP
elements	O
(	O
ROREs	O
)	O
and	O
one	O
PPAR	B-GP
response	O
element	O
(	O
PPRE	O
).	O

Five	O
different	O
sizes	O
of	O
mouse	B-OG
Fgf21	B-GP
promoter	O
fragments	O
were	O
amplified	O
by	O
PCR	O
and	O
cloned	O
into	O
pGL3	O
basic	O
vector	O
(	O
Promega	O
,	O
USA	O
)	O
using	O
following	O
primers	O
:	O
CGGTACCCTGAAGCCCCAGGTTC	O
(	O
R1_sense	O
primer	O
,	O
KpnI	B-GP
site	O
),	O
GCTCGAGCCAAGGCAGCTGGAATTG	O
(	O
R1_anti	O
-	O
sense	O
primer	O
,	O
XhoI	B-GP
site	O
),	O
CGGTACCCAGGAGGATGGAGAAC	O
(	O
R2_sense	O
primer	O
,	O
KpnI	B-GP
site	O
),	O
GCTCGAGGAACCTGGGGCTTCAG	O
(	O
R2_anti	O
-	O
sense	O
primer	O
,	O
XhoI	B-GP
site	O
),	O
CACGCGTGTCCGGCTTAGTGAAC	O
(	O
R3_sense	O
primer	O
,	O
MluI	B-GP
site	O
),	O
GCTCGAGGTTCTCCATCCTCCTG	O
(	O
R3_anti	O
-	O
sense	O
primer	O
,	O
XhoI	B-GP
site	O
),	O
CACGCGTCTCCTGTCCATTGCCAG	O
(	O
R4_sense	O
primer	O
,	O
MluI	B-GP
site	O
),	O
GCTCGAGGTTCACTAAGCCGGAC	O
(	O
R4_anti	O
-	O
sense	O
primer	O
,	O
XhoI	B-GP
site	O
),	O
CACGCGTCAGATTAAGCCACCGAGTC	O
(	O
sense	O
primer	O
,	O
MluI	B-GP
site	O
),	O
GCTCGAGCTGGTGAACGCAGAAATAC	O
(	O
anti	O
-	O
sense	O
primer	O
,	O
XhoI	B-GP
site	O
).	O

Generated	O
luciferase	B-GP
reporter	O
plasmids	O
were	O
designated	O
as	O
R1	O
(+	O
133	O
to	O
−	O
918	O
bp	O
),	O
R2	O
(−	O
919	O
to	O
−	O
1816	O
bp	O
),	O
R3	O
(−	O
1817	O
to	O
−	O
2892	O
bp	O
),	O
R4	O
(−	O
2893	O
to	O
−	O
4133	O
bp	O
)	O
and	O
Fgf21	B-GP
:	O
luc	B-GP
(+	O
2	O
to	O
−	O
3099	O
).	O

The	O
potential	O
RORE	O
and	O
HNF6	B-GP
binding	O
elements	O
were	O
mutated	O
by	O
site	O
-	O
directed	O
mutagenesis	O
using	O
the	O
following	O
primers	O
:	O
–	O
90	O
CCAAGTGGGCCCAGGATCCCGGGCCCGGAGTG	O
–	O
47	O
(	O
mut_R1	O
),	O
–	O
3058	O
TGAGATTTTCAGTGGGGCCCGGAGCTATGCAAAT	O
–	O
3023	O
(	O
mut_R4	O
)	O
and	O
–	O
117	O
CCTGGCCACGGTGGGCCCCCGGGTCCTGCCAAGTGTG	O
–	O
81	O
(	O
mut_Hnf6	O
).	O

Luciferase	B-GP
assays	O
were	O
performed	O
in	O
NIH3T3	O
cells	O
as	O
described	O
(	O
Langmesser	O
et	O
al	O
.,	O
2008	O
).	O

An	O
empty	O
pGL3	O
vector	O
was	O
used	O
as	O
negative	O
control	O
.	O
Bmal1	B-GP
::	O
luc	B-GP
and	O
Per1	B-GP
::	O
luc	B-GP
reporter	O
were	O
used	O
as	O
positive	O
controls	O
.	O

Knockdown	O
of	O
HNF6	B-GP
and	O
western	O
blot	O
analysis	O

24	O
h	O
after	O
seeding	O
cells	O
,	O
HNF6	B-GP
-	O
shRNA	O
plasmid	O
(	O
HNF	B-GP
-	I-GP
6	I-GP
sc	O
-	O
37937	O
-	O
SH	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
USA	O
)	O
was	O
used	O
for	O
knocking	O
-	O
down	O
of	O
HNF6	B-GP
,	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Scrambled	O
shRNA	O
plasmid	O
(	O
sc	O
-	O
108060	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
was	O
used	O
as	O
a	O
negative	O
control	O
.	O

Knockdown	O
efficiency	O
was	O
assessed	O
48	O
h	O
post	O
-	O
transfection	O
by	O
western	O
blotting	O
as	O
well	O
as	O
by	O
real	O
time	O
PCR	O
.	O

Protein	O
of	O
transfected	O
Hepa	O
-	O
1c1c7	O
cells	O
was	O
extracted	O
using	O
RIPA	O
buffer	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
pH	O
7	O
.	O
4	O
,	O
150	O
mM	O
NaCl	O
,	O
1	O
mM	O
EDTA	O
,	O
0	O
.	O
1	O
%	O
SDS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
0	O
.	O
5	O
%	O
sodium	O
deoxycholate	O
containing	O
protease	B-GP
and	O
phosphatase	B-GP
inhibitors	O
).	O

Protein	O
samples	O
were	O
subjected	O
to	O
electrophoresis	O
on	O
10	O
%	O
SDS	O
-	O
polyacrylamide	O
gels	O
and	O
transferred	O
to	O
a	O
nitrocellulose	O
(	O
Amersham	O
Protran	O
Supported	O
0	O
.	O
45	O
NC	O
,	O
GE	O
Healthcare	O
).	O

After	O
blocking	O
with	O
0	O
.	O
5	O
%	O
dry	O
milk	O
in	O
PBS	O
-	O
Tween	O
0	O
.	O
1	O
%,	O
the	O
membranes	O
were	O
probed	O
with	O
anti	O
-	O
HNF6	B-GP
(	O
1	O
:	O
500	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
sc	O
-	O
376167	O
),	O
and	O
HSP90	B-GP
(	O
1	O
:	O
1000	O
,	O
Santa	O
Cruz	O
Biotechnology	O
,	O
sc	O
-	O
13119	O
)	O
antibodies	B-GP
overnight	O
at	O
4	O
°	O
C	O
.	O

Anti	O
-	O
rabbit	B-OG
and	O
-	O
mouse	B-OG
HRP	B-GP
conjugated	O
antibody	B-GP
was	O
used	O
as	O
a	O
secondary	O
antibody	B-GP
.	O

Detection	O
of	O
the	O
immune	O
complexes	O
was	O
performed	O
using	O
WesternBright	O
Quantum	O
system	O
(	O
Advansta	O
,	O
K	O
-	O
12042	O
,	O
USA	O
)	O
and	O
quantification	O
was	O
done	O
with	O
the	O
Quantity	O
One	O
analysis	O
software	O
(	O
Bio	O
-	O
Rad	O
).	O

RNA	O
extraction	O
and	O
qPCR	O

Total	O
RNA	O
was	O
extracted	O
from	O
frozen	O
liver	O
using	O
RNA	O
-	O
Bee	O
(	O
AMS	O
Biotechnology	O
,	O
CS	O
-	O
105B	O
,	O
UK	O
).	O

RNA	O
samples	O
were	O
treated	O
with	O
DNase	B-GP
I	I-GP
(	O
Roche	O
),	O
and	O
purified	O
by	O
phenol	O
:	O
chloroform	O
extraction	O
and	O
ethanol	O
precipitation	O
.	O

cDNA	O
synthesis	O
was	O
carried	O
out	O
with	O
SuperScript	O
II	O
(	O
Invitrogen	O
)	O
and	O
SYBR	O
green	O
based	O
real	O
-	O
time	O
PCR	O
was	O
performed	O
for	O
mRNA	O
quantification	O
using	O
KAPA	O
SYBR	O
FAST	O
(	O
KAPA	O
Biosystems	O
,	O
KK	O
-	O
4601	O
,	O
UK	O
)	O
and	O
RotorGene	O
6000	O
(	O
Corbett	O
Research	O
,	O
RG	O
-	O
6000	O
,	O
Germany	O
).	O

All	O
RNA	O
samples	O
were	O
normalized	O
to	O
Gapdh	B-GP
.	O
Primers	O
are	O
:	O

Gapdh	B-GP
:	O

sense	O
:	O
5	O
′-	O
CATGGCCTTCCGTGTTCCTA	O
-	O
3	O
′	O

antisense	O
:	O
5	O
′-	O
CCTGCTTCACCACCTTCT	O
TGA	O
-	O
3	O
′;	O

Fgf21	B-GP
:	O

sense	O
:	O
5	O
′-	O
ACTGCTGCTGGACGGTTA	O
-	O
3	O
′	O

antisense	O
:	O
5	O
′-	O
GCATCCTGGTTTGGGGAGTCCTT	O
-	O
3	O
′;	O

Rev	B-GP
-	I-GP
erbα	I-GP
:	O

sense	O
:	O
5	O
′-	O
CAAGGCAACACCAAGAATGTT	O
-	O
3	O
′	O

antisense	O
:	O
5	O
′-	O
TTCCCAGATCTCCTGCACAGT	O
-	O
3	O
′;	O

Hnf6	B-GP
:	O

sense	O
:	O
5	O
′-	O
CCCTGGAGCAAACTCAAGTC	O
-	O
3	O
′	O

antisense	O
:	O
5	O
′-	O
GGTCTCTTTCCG	O
TGCTGCTA	O
-	O
3	O
′.	O

The	O
values	O
were	O
calculated	O
using	O
the	O
double	O
delta	O
Ct	O
method	O
.	O

81	O
cycles	O
of	O
10	O
s	O
at	O
55	O
°	O
C	O
with	O
increasing	O
increments	O
of	O
0	O
.	O
5	O
°	O
C	O
per	O
cycle	O
was	O
performed	O
for	O
melting	O
curve	O
analysis	O
.	O

A	O
negative	O
control	O
for	O
each	O
primer	O
pair	O
was	O
included	O
on	O
each	O
plate	O
.	O

Melting	O
curve	O
analysis	O
was	O
performed	O
to	O
confirm	O
that	O
only	O
one	O
product	O
was	O
amplified	O
and	O
there	O
were	O
not	O
any	O
products	O
in	O
negative	O
controls	O
.	O

LinRegPCR	O
was	O
used	O
to	O
calculate	O
PCR	O
efficiencies	O
for	O
each	O
sample	O
.	O

The	O
RNA	O
source	O
,	O
Average	O
Ct	O
,	O
working	O
annealing	O
temperature	O
,	O
the	O
average	O
amplification	O
efficiency	O
and	O
coefficients	O
of	O
variation	O
are	O
given	O
for	O
each	O
gene	O
in	O
Table	O
S1	O
.	O

Chromatin	O
immunoprecipitation	O

For	O
the	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
experiments	O
,	O
mice	B-OG
were	O
sacrificed	O
at	O
ZT10	O
and	O
ZT22	O
.	O

The	O
livers	O
of	O
mice	B-OG
were	O
homogenized	O
in	O
1	O
×	O
phosphate	O
-	O
buffered	O
saline	O
supplemented	O
with	O
1	O
%	O
formaldehyde	O
,	O
incubated	O
for	O
5	O
min	O
at	O
room	O
temperature	O
,	O
and	O
nuclei	O
and	O
chromatin	O
prepared	O
according	O
to	O
(	O
Schmutz	O
et	O
al	O
.,	O
2010	O
).	O

Briefly	O
,	O
pure	O
liver	O
nuclei	O
form	O
each	O
mouse	B-OG
were	O
obtained	O
by	O
centrifugation	O
through	O
2	O
.	O
05	O
M	O
sucrose	O
cushions	O
and	O
the	O
chromatin	O
in	O
500	O
μl	O
of	O
1	O
%	O
SDS	O
,	O
20	O
mM	O
Tris	O
pH	O
7	O
.	O
4	O
,	O
150	O
mM	O
NaCl	O
,	O
and	O
2	O
mM	O
EDTA	O
was	O
fragmented	O
by	O
sonication	O
(	O
10	O
×	O
10	O
s	O
pulses	O
at	O
50	O
%	O
intensity	O
using	O
a	O
Branson	O
SLPe	O
device	O
equipped	O
with	O
a	O
microtip	O
).	O

After	O
a	O
10	O
-	O
fold	O
dilution	O
with	O
1	O
.	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
20	O
mM	O
Tris	O
pH	O
7	O
.	O
4	O
,	O
150	O
mM	O
NaCl	O
,	O
and	O
2	O
mM	O
EDTA	O
,	O
200	O
μl	O
of	O
chromatin	O
were	O
used	O
per	O
reaction	O
.	O

DNA	O
fragments	O
precipitated	O
with	O
anti	O
-	O
REV	B-GP
-	I-GP
ERBα	I-GP
antibody	B-GP
(	O
1	O
:	O
50	O
dilution	O
;	O
SAB2101632	O
;	O
Sigma	O
-	O
Aldrich	O
),	O
with	O
anti	O
-	O
HNF6	B-GP
(	O
G	O
-	O
10	O
)	O
(	O
1	O
:	O
30	O
dilution	O
;	O
sc	O
-	O
376167	O
,	O
Santa	O
Cruz	O
Biotechnology	O
),	O
with	O
anti	O
-	O
PPARα	B-GP
(	O
1	O
:	O
25	O
dilution	O
;	O
101710	O
;	O
Cayman	O
Chemical	O
Company	O
,	O
USA	O
)	O
or	O
with	O
anti	O
-	O
PER2	B-GP
(	O
1	O
:	O
25	O
dilution	O
;	O
No	O
.	O
611138	O
;	O
BD	O
Transduction	O
Laboratories	O
)	O
were	O
detected	O
with	O
the	O
reverse	O
transcription	O
PCR	O
primers	O
and	O
probes	O
enlisted	O
in	O
Table	O
S2	O
.	O

Along	O
the	O
samples	O
,	O
1	O
%	O
of	O
the	O
input	O
was	O
processed	O
and	O
the	O
%	O
of	O
input	O
calculated	O
as	O
precipitated	O
material	O
/(	O
amount	O
of	O
input	O
×	O
100	O
).	O

Competing	O
interests	O

The	O
authors	O
declare	O
no	O
competing	O
or	O
financial	O
interests	O
.	O

Author	O
contributions	O

U	O
.	O
A	O
.	O
and	O
N	O
.	O
Pi	O
.	O
conceived	O
,	O
designed	O
and	O
interpreted	O
the	O
experiments	O
.	O

R	O
.	O
C	O
.,	O
N	O
.	O
Pr	O
.,	O
T	O
.	O
O	O
,	O
L	O
.	O
M	O
.	O
S	O
.,	O
C	O
.	O
X	O
.	O
and	O
J	O
.	O
A	O
.	O
R	O
.	O
performed	O
the	O
experiments	O
.	O

U	O
.	O
A	O
.	O
wrote	O
the	O
manuscript	O
and	O
all	O
authors	O
reviewed	O
the	O
manuscript	O
.	O

Funding	O

This	O
work	O
was	O
supported	O
by	O
a	O
Sinergia	O
Grant	O
from	O
Schweizerischer	O
Nationalfonds	O
zur	O
Förderung	O
der	O
Wissenschaftlichen	O
Forschung	O
(	O
Swiss	O
National	O
Science	O
Foundation	O
)	O
(	O
CRSII3_141960	O
/	O
1	O
)	O
and	O
the	O
States	O
of	O
Fribourg	O
and	O
Vaud	O
.	O

Supplementary	O
information	O

Supplementary	O
information	O
available	O
online	O
at	O
http	O
://	O
bio	O
.	O
biologists	O
.	O
org	O
/	O
lookup	O
/	O
doi	O
/	O
10	O
.	O
1242	O
/	O
bio	O
.	O
021519	O
.	O
supplemental	O
.	O

